Skip to main content
Erschienen in: The Cerebellum 2/2017

01.04.2017 | Short Report

Corticomuscular Coherence: a Novel Tool to Assess the Pyramidal Tract Dysfunction in Spinocerebellar Ataxia Type 2

verfasst von: Luis Velázquez-Pérez, Johannes Tünnerhoff, Roberto Rodríguez-Labrada, Reidenis Torres-Vega, Paolo Belardinelli, Jacqueline Medrano-Montero, Arnoy Peña-Acosta, Nalia Canales-Ochoa, Yaimeé Vázquez-Mojena, Yanetza González-Zaldivar, Georg Auburger, Ulf Ziemann

Erschienen in: The Cerebellum | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Clinical signs of corticospinal tract dysfunction are a common feature of spinocerebellar ataxia type 2 (SCA2) patients. The objective of this study is to assess dysfunction of the corticospinal tract in SCA2 using corticomuscular coherence. Testing corticomuscular coherence and rating of ataxia severity and non-ataxia symptoms were performed in 19 SCA2 patients and 24 age-matched controls. Central motor conduction times (CMCT) to upper and lower right limbs were obtained for the SCA2 group using Transcraneal magnetic stimulation (TMS). SCA2 patients exhibited a significant reduction of corticomuscular coherence for lower limbs, but not for upper limbs. This difference remained significant, even when excluding those individuals with clinical signs of corticospinal tract dysfunction. Corticomuscular coherence for lower limbs correlated inversely with CMCT to tibialis anterior muscle. Corticomuscular coherence could be a valuable electrophysiological tool to assess the corticospinal tract involvement in SCA2, even in the absence of clinical signs of corticospinal tract dysfunction.
Literatur
2.
Zurück zum Zitat Satterfield TF, Jackson SM, Pallanck LJ. A Drosophila homolog of the polyglutamine disease gene SCA2 is a dosage-sensitive regulator of actin filament formation. Genetics. 2002;162(4):1687–702.PubMedPubMedCentral Satterfield TF, Jackson SM, Pallanck LJ. A Drosophila homolog of the polyglutamine disease gene SCA2 is a dosage-sensitive regulator of actin filament formation. Genetics. 2002;162(4):1687–702.PubMedPubMedCentral
3.
Zurück zum Zitat van den Heuvel DM, Harschnitz O, van den Berg LH, Pasterkamp RJ. Taking a risk: a therapeutic focus on ataxin-2 in amyotrophic lateral sclerosis? Trends Mol Med. 2014;20(1):25–35.CrossRefPubMed van den Heuvel DM, Harschnitz O, van den Berg LH, Pasterkamp RJ. Taking a risk: a therapeutic focus on ataxin-2 in amyotrophic lateral sclerosis? Trends Mol Med. 2014;20(1):25–35.CrossRefPubMed
4.
Zurück zum Zitat Velázquez-Pérez L, Rodríguez-Labrada R, Canales-Ochoa N, et al. Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study. Lancet Neurol. 2014;13(5):482–9.CrossRefPubMed Velázquez-Pérez L, Rodríguez-Labrada R, Canales-Ochoa N, et al. Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study. Lancet Neurol. 2014;13(5):482–9.CrossRefPubMed
5.
Zurück zum Zitat Velázquez-Pérez L, Rodríguez-Labrada R, Cruz-Rivas EM, et al. Comprehensive study of early features in spinocerebellar ataxia 2: delineating the prodromal stage of the disease. Cerebellum. 2014;13(5):568–79.CrossRefPubMed Velázquez-Pérez L, Rodríguez-Labrada R, Cruz-Rivas EM, et al. Comprehensive study of early features in spinocerebellar ataxia 2: delineating the prodromal stage of the disease. Cerebellum. 2014;13(5):568–79.CrossRefPubMed
6.
Zurück zum Zitat Farmer SF, Bremner FD, Halliday DM, Rosenberg JR, Stephens JA. The frequency content of common synaptic inputs to motoneurones studied during voluntary isometric contraction in man. J Physiol (Lond). 1993;470:127–55.CrossRef Farmer SF, Bremner FD, Halliday DM, Rosenberg JR, Stephens JA. The frequency content of common synaptic inputs to motoneurones studied during voluntary isometric contraction in man. J Physiol (Lond). 1993;470:127–55.CrossRef
7.
Zurück zum Zitat Ushiyama J, Takahashi Y, Ushiba J. Muscle dependency of corticomuscular coherence in upper and lower limb muscles and training-related alterations in ballet dancers and weightlifters. J Appl Physiol (1985). 2010;109(4):1086–95.CrossRef Ushiyama J, Takahashi Y, Ushiba J. Muscle dependency of corticomuscular coherence in upper and lower limb muscles and training-related alterations in ballet dancers and weightlifters. J Appl Physiol (1985). 2010;109(4):1086–95.CrossRef
8.
Zurück zum Zitat Caviness JN, Shill HA, Sabbagh MN, Evidente VG, Hernandez JL, Adler CH. Corticomuscular coherence is increased in the small postural tremor of Parkinson’s disease. Mov Disord. 2006;21(4):492–9.CrossRefPubMed Caviness JN, Shill HA, Sabbagh MN, Evidente VG, Hernandez JL, Adler CH. Corticomuscular coherence is increased in the small postural tremor of Parkinson’s disease. Mov Disord. 2006;21(4):492–9.CrossRefPubMed
10.
Zurück zum Zitat von Carlowitz-Ghori K, Bayraktaroglu Z, Hohlefeld FU, Losch F, Curio G, Nikulin VV. Corticomuscular coherence in acute and chronic stroke. Clin Neurophysiol. 2014;125:1182–91.CrossRef von Carlowitz-Ghori K, Bayraktaroglu Z, Hohlefeld FU, Losch F, Curio G, Nikulin VV. Corticomuscular coherence in acute and chronic stroke. Clin Neurophysiol. 2014;125:1182–91.CrossRef
11.
Zurück zum Zitat Schmitz-Hübsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66:1717–20.CrossRefPubMed Schmitz-Hübsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66:1717–20.CrossRefPubMed
12.
Zurück zum Zitat Schmitz-Hübsch T, Coudert M, Bauer P, et al. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology. 2008;71:982–9.CrossRefPubMed Schmitz-Hübsch T, Coudert M, Bauer P, et al. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology. 2008;71:982–9.CrossRefPubMed
13.
Zurück zum Zitat Oostenveld R, Fries P, Maris E, Schoffelen JM. FieldTrip: Open source software for advanced analysis of MEG, EEG, and invasive electrophysiological data. Comput Intell Neurosci. 2011;2011:156869.CrossRefPubMed Oostenveld R, Fries P, Maris E, Schoffelen JM. FieldTrip: Open source software for advanced analysis of MEG, EEG, and invasive electrophysiological data. Comput Intell Neurosci. 2011;2011:156869.CrossRefPubMed
14.
Zurück zum Zitat McClelland VM, Cvetkovic Z, Mills KR. Rectification of the EMG is an unnecessary and inappropriate step in the calculation of Corticomuscular coherence. J Neurosci Methods. 2012;205(1):190–201.CrossRefPubMed McClelland VM, Cvetkovic Z, Mills KR. Rectification of the EMG is an unnecessary and inappropriate step in the calculation of Corticomuscular coherence. J Neurosci Methods. 2012;205(1):190–201.CrossRefPubMed
15.
Zurück zum Zitat Maris E, Oostenveld R. Nonparametric statistical testing of EEG- and MEG-data. J Neurosci Methods. 2007;164:177–90.CrossRefPubMed Maris E, Oostenveld R. Nonparametric statistical testing of EEG- and MEG-data. J Neurosci Methods. 2007;164:177–90.CrossRefPubMed
16.
Zurück zum Zitat Fisher KM, Zaaimi B, Williams TL, Baker SN, Baker MR. Beta-band intermuscular coherence: a novel biomarker of upper motor neuron dysfunction in motor neuron disease. Brain. 2012;135:2849–64.CrossRefPubMedPubMedCentral Fisher KM, Zaaimi B, Williams TL, Baker SN, Baker MR. Beta-band intermuscular coherence: a novel biomarker of upper motor neuron dysfunction in motor neuron disease. Brain. 2012;135:2849–64.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Velazquez-Perez L, Rodriguez-Labrada R, Torres-Vega R, et al. Central motor conduction time as prodromal biomarker in spinocerebellar ataxia type 2. Mov Disord. 2016;31(4):603–4.CrossRefPubMed Velazquez-Perez L, Rodriguez-Labrada R, Torres-Vega R, et al. Central motor conduction time as prodromal biomarker in spinocerebellar ataxia type 2. Mov Disord. 2016;31(4):603–4.CrossRefPubMed
18.
Zurück zum Zitat Velazquez-Perez L, Rodriguez-Labrada R, Torres-Vega R, et al. Abnormal corticospinal tract function and motor cortex excitability in non-ataxic SCA2 mutation carriers: a TMS study. Clin Neurophysiol. 2016;127:2713–9.CrossRefPubMed Velazquez-Perez L, Rodriguez-Labrada R, Torres-Vega R, et al. Abnormal corticospinal tract function and motor cortex excitability in non-ataxic SCA2 mutation carriers: a TMS study. Clin Neurophysiol. 2016;127:2713–9.CrossRefPubMed
19.
Zurück zum Zitat Robinson IR, Janton P, McLean IC. Central motor conduction times using transcranial magnetic stimulation and F waves latencies. Muscle Nerve. 1988;11:174–80.CrossRef Robinson IR, Janton P, McLean IC. Central motor conduction times using transcranial magnetic stimulation and F waves latencies. Muscle Nerve. 1988;11:174–80.CrossRef
20.
Zurück zum Zitat Seidel K, Siswanto S, Brunt ER, den Dunnen W, Korf HW, Rüb U. Brain pathology of spinocerebellar ataxias. Acta Neuropathol. 2012;124(1):1–21.CrossRefPubMed Seidel K, Siswanto S, Brunt ER, den Dunnen W, Korf HW, Rüb U. Brain pathology of spinocerebellar ataxias. Acta Neuropathol. 2012;124(1):1–21.CrossRefPubMed
21.
Zurück zum Zitat Kuypers H. The anatomical organization of the descending pathways and their contributions to motor control especially in primates. In: Desmedt JE, ed. New developments in electromyography and clinical neuro-physiology, vol. 3 Basel: Karger 1973: 38–68. Kuypers H. The anatomical organization of the descending pathways and their contributions to motor control especially in primates. In: Desmedt JE, ed. New developments in electromyography and clinical neuro-physiology, vol. 3 Basel: Karger 1973: 38–68.
22.
Zurück zum Zitat Restivo DA, Giuffrida S, Rapisarda G, Antonuzzo A, Saponara R, Reggio A, et al. Central motor conduction to lower limb after transcranial magnetic stimulation in spinocerebellar ataxia type 2 (SCA2). Clin Neurophysiol. 2000;111(4):630–5.CrossRefPubMed Restivo DA, Giuffrida S, Rapisarda G, Antonuzzo A, Saponara R, Reggio A, et al. Central motor conduction to lower limb after transcranial magnetic stimulation in spinocerebellar ataxia type 2 (SCA2). Clin Neurophysiol. 2000;111(4):630–5.CrossRefPubMed
23.
Zurück zum Zitat Rossini PM, Caramia MD. Methodological and physiological considerations on the electric or magnetic transcranial stimulation. In: Rossini PM, Marsden CD, editors. Non-invasive stimulation of brain and spinal cord: fundamentals and clinical applications. New York: Alan R. Liss; 1988. p. 37–65. Rossini PM, Caramia MD. Methodological and physiological considerations on the electric or magnetic transcranial stimulation. In: Rossini PM, Marsden CD, editors. Non-invasive stimulation of brain and spinal cord: fundamentals and clinical applications. New York: Alan R. Liss; 1988. p. 37–65.
24.
Zurück zum Zitat Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069–75.CrossRefPubMedPubMedCentral Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069–75.CrossRefPubMedPubMedCentral
Metadaten
Titel
Corticomuscular Coherence: a Novel Tool to Assess the Pyramidal Tract Dysfunction in Spinocerebellar Ataxia Type 2
verfasst von
Luis Velázquez-Pérez
Johannes Tünnerhoff
Roberto Rodríguez-Labrada
Reidenis Torres-Vega
Paolo Belardinelli
Jacqueline Medrano-Montero
Arnoy Peña-Acosta
Nalia Canales-Ochoa
Yaimeé Vázquez-Mojena
Yanetza González-Zaldivar
Georg Auburger
Ulf Ziemann
Publikationsdatum
01.04.2017
Verlag
Springer US
Erschienen in
The Cerebellum / Ausgabe 2/2017
Print ISSN: 1473-4222
Elektronische ISSN: 1473-4230
DOI
https://doi.org/10.1007/s12311-016-0827-4

Weitere Artikel der Ausgabe 2/2017

The Cerebellum 2/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.